Moreover, our in vitro and in vivo findings in pancreatic adenocarcinoma—a tumor type with one of the highest KRAS mutation rates—further indicate that COA4 knockdown suppresses metastasis. Here, COA4 is linked to pancreatic adenocarcinoma.